William J Ravich1,2. 1. The Johns Hopkins University School of Medicine, Baltimore, MD, USA. wravich1@jhmi.edu. 2. , 10751 Falls Road, Suite 401, Lutherville, MD, 21093, USA. wravich1@jhmi.edu.
Abstract
PURPOSE OF REVIEW: This paper presents the author's approach to esophageal dilation. It offers a tailored approach to the application of dilation to specific types of esophageal stenotic lesions. RECENT FINDINGS: In patients with inflammatory stricture, recent studies confirm the importance of treating the underlying inflammatory condition in order to decrease the rate of recurrence. The paper reviews some of the novel techniques that have been suggested for the treatment of refractory benign esophageal strictures, including incisional therapy, stenting, or the injection steroids or antifibrotic agents. The endoscopist who treats esophageal strictures must be familiar with the tools of the dilation and how they are best applied to specific types of stenotic lesions. If inflammation is present, effective management requires treatment of the inflammatory process in addition to mechanical dilation of the stenotic lesion. Controlled trials of novel approaches to treatment of refractory benign esophageal strictures are limited and will be necessary to determine efficacy.
PURPOSE OF REVIEW: This paper presents the author's approach to esophageal dilation. It offers a tailored approach to the application of dilation to specific types of esophageal stenotic lesions. RECENT FINDINGS: In patients with inflammatory stricture, recent studies confirm the importance of treating the underlying inflammatory condition in order to decrease the rate of recurrence. The paper reviews some of the novel techniques that have been suggested for the treatment of refractory benign esophageal strictures, including incisional therapy, stenting, or the injection steroids or antifibrotic agents. The endoscopist who treats esophageal strictures must be familiar with the tools of the dilation and how they are best applied to specific types of stenotic lesions. If inflammation is present, effective management requires treatment of the inflammatory process in addition to mechanical dilation of the stenotic lesion. Controlled trials of novel approaches to treatment of refractory benign esophageal strictures are limited and will be necessary to determine efficacy.
Authors: Chris A Liacouras; Glenn T Furuta; Ikuo Hirano; Dan Atkins; Stephen E Attwood; Peter A Bonis; A Wesley Burks; Mirna Chehade; Margaret H Collins; Evan S Dellon; Ranjan Dohil; Gary W Falk; Nirmala Gonsalves; Sandeep K Gupta; David A Katzka; Alfredo J Lucendo; Jonathan E Markowitz; Richard J Noel; Robert D Odze; Philip E Putnam; Joel E Richter; Yvonne Romero; Eduardo Ruchelli; Hugh A Sampson; Alain Schoepfer; Nicholas J Shaheen; Scott H Sicherer; Stuart Spechler; Jonathan M Spergel; Alex Straumann; Barry K Wershil; Marc E Rothenberg; Seema S Aceves Journal: J Allergy Clin Immunol Date: 2011-04-07 Impact factor: 10.793
Authors: Marjan L Hordijk; Jeanin E van Hooft; Bettina E Hansen; Paul Fockens; Ernst J Kuipers Journal: Gastrointest Endosc Date: 2009-07-01 Impact factor: 9.427
Authors: Karina V Grooteman; Louis M Wong Kee Song; Frank P Vleggaar; Peter D Siersema; Todd H Baron Journal: Gastrointest Endosc Date: 2016-08-06 Impact factor: 9.427
Authors: Ioannis Oikonomakis; Daniel T Jansson; Per Skoog; Kristofer F Nilsson; Adrian D Meehan; Tal M Hörer; Kjell Jansson Journal: JGH Open Date: 2022-05-06
Authors: Iatagan R Josino; Antônio C Madruga-Neto; Igor B Ribeiro; Hugo G Guedes; Vitor O Brunaldi; Diogo T H de Moura; Wanderley M Bernardo; Eduardo G H de Moura Journal: Gastroenterol Res Pract Date: 2018-07-15 Impact factor: 2.260